Net Cash Provided by (Used in) Financing Activities of NEXIEN BIOPHARMA, INC. from 30 Jun 2014 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
NEXIEN BIOPHARMA, INC. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Jun 2014 to 30 Sep 2024.
  • NEXIEN BIOPHARMA, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Sep 2024 was $10,000.
  • NEXIEN BIOPHARMA, INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $33,400.
  • NEXIEN BIOPHARMA, INC. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $174,000, a 78% increase from 2021.
  • NEXIEN BIOPHARMA, INC. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $98,000, a 717% increase from 2020.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

NEXIEN BIOPHARMA, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $10,000 01 Jul 2024 30 Sep 2024 10-Q 18 Nov 2024 2025 Q1
Q3 2020 $13,000 01 Jul 2020 30 Sep 2020 10-Q 22 Nov 2021 2022 Q1
Q3 2017 $909,036 +$903,706 +16955% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2019 Q1
Q2 2017 $575,955 27 Mar 2017 30 Jun 2017 10-K 28 Sep 2018 2018 FY
Q3 2016 $5,330 +$106 +2% 01 Jul 2016 30 Sep 2016 10-Q 03 Nov 2017 2018 Q1
Q4 2015 $8,774 +$8,774 01 Oct 2015 31 Dec 2015 10-Q 04 Feb 2016 2016 Q2
Q3 2015 $5,224 +$5,224 01 Jul 2015 30 Sep 2015 10-Q 19 Oct 2016 2017 Q1
Q4 2014 $0 01 Oct 2014 31 Dec 2014 10-Q 04 Feb 2016 2016 Q2
Q3 2014 $0 01 Jul 2014 30 Sep 2014 10-Q 14 Oct 2015 2016 Q1

NEXIEN BIOPHARMA, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $33,400 01 Jul 2023 30 Jun 2024 10-K 22 Oct 2024 2024 FY
2022 $174,000 +$76,000 +78% 01 Jul 2021 30 Jun 2022 10-K 28 Sep 2023 2023 FY
2021 $98,000 +$86,000 +717% 01 Jul 2020 30 Jun 2021 10-K 28 Sep 2022 2022 FY
2020 $12,000 01 Jul 2019 30 Jun 2020 10-K 12 Oct 2021 2021 FY
2018 $1,500,203 +$1,484,373 +9377% 01 Jul 2017 30 Jun 2018 10-K 30 Sep 2019 2019 FY
2017 $15,830 -$522 -3.2% 01 Jul 2016 30 Jun 2017 10-K 31 Jul 2017 2017 FY
2016 $16,352 -$30,378 -65% 01 Jul 2015 30 Jun 2016 10-K 31 Jul 2017 2017 FY
2015 $46,730 +$46,280 +10284% 01 Jul 2014 30 Jun 2015 10-K 28 Sep 2016 2016 FY
2014 $450 01 Jul 2013 30 Jun 2014 10-K 15 Sep 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.